Association between midlife dementia risk factors and longitudinal brain atrophy: the PREVENT-Dementia study
Tóm tắt
Increased rates of brain atrophy on serial MRI are frequently used as a surrogate marker of disease progression in Alzheimer’s disease and other dementias. However, the extent to which they are associated with future risk of dementia in asymptomatic subjects is not clear. In this study, we investigated the relationship between the Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) risk score and longitudinal atrophy in middle-aged subjects.
A sample of 167 subjects (aged 40–59 at baseline) from the PREVENT-Dementia programme underwent MRI scans on two separate occasions (mean interval 735 days; SD 44 days). We measured longitudinal rates of brain atrophy using the FSL Siena toolbox.
Annual percentage rates of brain volume and ventricular volume change were greater in those with a high (>6) vs low CAIDE score—absolute brain volume percentage loss 0.17% (CI 0.07 to 0.27) and absolute ventricular enlargement 1.78% (CI 1.14 to 2.92) higher in the at risk group. Atrophy rates did not differ between subjects with and without a parental history of dementia, but were significantly correlated with age. Using linear regression, with covariates of age, sex and education, CAIDE score >6 was the only significant predictor of whole brain atrophy rates (p=0.025) while age (p=0.009), sex (p=0.002) and CAIDE>6 (p=0.017) all predicted ventricular expansion rate.
Our results show that progressive brain atrophy is associated with increased risk of future dementia in asymptomatic middle-aged subjects, two decades before dementia onset.
Từ khóa
Tài liệu tham khảo
Ritchie, 2015, Is late-onset Alzheimer's disease really a disease of midlife?, Alzheimers Dement, 1, 122
Tang, 2015, Current developments in dementia risk prediction modelling: an updated systematic review, PLoS One, 10, 10.1371/journal.pone.0136181
Ritchie, 2017, The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: the prevent study, Alzheimers Dement, 13, 1089, 10.1016/j.jalz.2017.02.008
Stephen, 2017, Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition, J Alzheimers Dis, 59, 695, 10.3233/JAD-170092
Mosconi, 2018, Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area, BMJ Open, 8, 10.1136/bmjopen-2017-019362
McIntosh, 2017, Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome?, Neurosci Lett, 636, 225, 10.1016/j.neulet.2016.10.010
Ritchie, 2012, The prevent study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease, BMJ Open, 2, 10.1136/bmjopen-2012-001893
Vuorinen, 2015, Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging, J Alzheimers Dis, 44, 93, 10.3233/JAD-140924
Vinke, 2018, Trajectories of imaging markers in brain aging: the Rotterdam study, Neurobiol Aging, 71, 32, 10.1016/j.neurobiolaging.2018.07.001
Licher, 2018, External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam study, Eur J Epidemiol, 33, 645, 10.1007/s10654-018-0403-y